Back to Search
MICHAEL LANNING, PHARMD
PHARMD
Pharmacy
NPI: 1235772401Individual
Specialties, Licenses & Credentials
PharmacyPrimary
Pharmacy
Code: 333600000X
0010317(OR)
Research & Publications (14)
Progressive neurocognitive impairment in young adult survivors of childhood acute lymphoblastic leukemia.
PMID 19405135·Pediatr Blood Cancer·2009
8-other
Radiation-induced meningiomas: a shadow in the success story of childhood leukemia.
PMID 19179425·Neuro Oncol·2009
8-other
Osteonecrosis in children treated for lymphoma or solid tumors.
PMID 18989155·J Pediatr Hematol Oncol·2008
8-other
Scholastic achievements of childhood leukemia patients: a nationwide, register-based study.
PMID 17687156·J Clin Oncol·2007
8-other
High body mass index increases the risk for osteonecrosis in children with acute lymphoblastic leukemia.
PMID 17442991·J Clin Oncol·2007
8-other
Radiation dose and relapse are predictors for development of second malignant solid tumors after cancer in childhood and adolescence: a population-based case-control study in the five Nordic countries.
PMID 16760180·Acta Oncol·2006
8-other
Outcome of children with high-risk acute lymphoblastic leukemia (HR-ALL): Nordic results on an intensive regimen with restricted central nervous system irradiation.
PMID 14752789·Pediatr Blood Cancer·2004
8-other
Perfusion MRI and SPECT of brain after treatment for childhood acute lymphoblastic leukemia.
PMID 12461791·Med Pediatr Oncol·2003
4-observational
Cognitive functions of young adults who survived childhood cancer.
PMID 11989726·Appl Neuropsychol·2001
3-trial
White matter changes on MRI during treatment in children with acute lymphoblastic leukemia: correlation with neuropsychological findings.
PMID 11070477·Med Pediatr Oncol·2000
8-other
Second malignant neoplasms after cancer in childhood and adolescence: a population-based case-control study in the 5 Nordic countries. The Nordic Society for Pediatric Hematology and Oncology. The Association of the Nordic Cancer Registries.
PMID 11058888·Int J Cancer·2000
4-observational
Granulocyte-macrophage colony-stimulating factor support in therapy of high-risk acute lymphoblastic leukemia in children.
PMID 10797353·Med Pediatr Oncol·2000
4-observational
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 2825 E BARNETT RD
MEDFORD, OR 97504 - Phone
- (541) 789-2133
Quick Facts
- NPI
- 1235772401
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 14
Are you this provider?
Claim Your Profile